Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People who have been diagnosed with chronic (long-term) heart failure
- People who are already receiving the recommended standard treatments for heart failure, including both medications and any relevant devices
- People whose heart pumping strength (called ejection fraction) is measured at 40% or below on an ultrasound of the heart
- People whose heart failure symptoms fall into a moderate category — specifically, those with mild limitations on physical activity (NYHA Class II), or those with more noticeable limitations (NYHA Class III) who also have at least one of the following: a hospital stay for heart failure in the past 12 months, or a specific heart-stress marker (BNP or NT-proBNP) in the blood that was above a certain level in the past 3 months (confirm with trial site for exact levels and whether this applies based on heart rhythm and current medications)
- People who are able to complete a 6-minute walking test, covering a distance of between 100 and 450 metres
Who may not be able to join:
- People whose heart failure has recently worsened severely, requiring hospitalisation in the past 2 weeks, or whose heart failure is at an advanced stage with no response to treatment, or who are already listed for a heart transplant or a mechanical heart pump device
- People whose body weight falls outside a healthy range — specifically, a BMI above 40 or below 18.5
- People whose resting blood pressure is either too low (below 90 mmHg) or too high (160 mmHg or above)
- People with moderate or severe narrowing of the aortic or mitral heart valves, or who are expected to need a procedure during the trial for severe leaking of any of the four heart valves
- People who have coronary artery disease that requires a procedure to restore blood flow to the heart
- People whose heart failure is caused by specific conditions such as an abnormally thickened heart muscle, active inflammation of the heart, fluid around the heart, or a heart defect present from birth
- People who have had a stroke, a mini-stroke (TIA), a blood clot in a deep vein, or a blood clot in the lungs within the past 3 months
- People with serious long-term lung disease that requires ongoing oxygen therapy or regular steroid medication
- People who have had a procedure involving puncture of the wall between the upper chambers of the heart within the past 3 months (such as certain heart valve repairs, procedures for irregular heart rhythm, or closure of a part of the heart called the left atrial appendage)
- People with significant weakness of the right side of the heart, based on specific measurements taken during a heart ultrasound (confirm with trial site)
- People with significantly reduced kidney function, based on a blood test result below a certain threshold (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 0571 87783759
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Primary Safety endpoint; Composite Primary Effective endpoint
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.